Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Whitehawk Therapeutics, Inc. (WHWK) had Free Cash Flow per Share of $-0.95 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-52.62M |
|
-- |
|
-- |
|
$54.75M |
|
$-54.75M |
|
$2.13M |
|
$-52.62M |
|
$-52.62M |
|
$-52.62M |
|
$-52.62M |
|
$-52.62M |
|
$-52.62M |
|
$-54.75M |
|
$-54.73M |
|
69.08M |
|
69.08M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$178.67M |
|
$0.01M |
|
$2.15M |
|
$180.82M |
|
$8.76M |
|
-- |
|
-- |
|
$8.76M |
|
$172.07M |
|
$172.07M |
|
$172.07M |
|
47.13M |
|
| Cash Flow Statement Financials | |
$-64.82M |
|
$86.67M |
|
$94.35M |
|
$28.73M |
|
$144.94M |
|
$116.20M |
|
$4.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-65.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.58% |
|
-30.58% |
|
-29.10% |
|
-30.58% |
|
$3.65 |
|
|
Free Cash Flow per Share |
$-0.95 |
$-0.94 |
|